If you liked this article you might like

Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan
Allergan's Vitae Buy Could Spark More Interest in Kadmon
5 Healthy Pharma and Biotech Plays
Agios Shares Spike on Planned Drug Application